help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meerschaert, J.
Right arrow Articles by Mosher, D. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meerschaert, J.
Right arrow Articles by Mosher, D. F.

Am. J. Respir. Cell Mol. Biol., Volume 23, Number 6, December, 2000 780-787

CD14+ Cells Are Necessary for Increased Survival of Eosinophils in Response to Lipopolysaccharide

JoAnn Meerschaert, William W. Busse, Paul J. Bertics, and Deane F. Mosher

Departments of Medicine and Biomolecular Chemistry, University of Wisconsin, Madison, Wisconsin; and Department of Biological Sciences, St. Cloud State University, St. Cloud, Minnesota

There has been considerable interest in the effect that gram-negative bacterial endotoxin (lipopolysaccharide [LPS]) can have in asthma, given that inhalation of LPS has been shown to cause bronchial hyperresponsiveness. Further, there is evidence that the endotoxin-binding protein CD14 may be a marker for asthma. Inhaled LPS has been shown to cause an influx of eosinophils into the nasal airway and to increase the survival of CD16-negatively selected eosinophils in vitro. In this study, we compared survival of eosinophils isolated via CD16-negative selection with eosinophils that were isolated using both CD16- and CD14-negative selection criteria. Survival of CD16-negatively selected eosinophils was enhanced by LPS in a dose-dependent manner and was inhibited by the endotoxin antagonists polymyxin B or lipid X. In contrast, depletion of CD14+ cells within the eosinophil preparations (CD14/CD16-negatively selected eosinophils) decreased the effect of LPS on survival. Preincubation of CD16-negatively selected eosinophils with antibody 60bd, which blocks LPS binding to CD14, prevented the survival-enhancing effect of LPS. However, CD14 was not detected on eosinophils by flow cytometry, even after incubation with LPS for up to 24 h. These results suggest that the survival-enhancing effect of LPS on eosinophils requires the presence of CD14+ cells in the population. It is our hypothesis that enhanced eosinophil survival with LPS involves the contribution of another cell type.




This article has been cited by other articles:


Home page
 Am. J. Respir. Crit. Care Med.Home page
I. Sabroe, L. C. Parker, D. H. Dockrell, D. E. Davies, S. K. Dower, and M. K. B. Whyte
Targeting the Networks that Underpin Contiguous Immunity in Asthma and Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., February 15, 2007; 175(4): 306 - 311.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
L. C. Parker, M. K. B. Whyte, S. K. Dower, and I. Sabroe
The expression and roles of Toll-like receptors in the biology of the human neutrophil
J. Leukoc. Biol., June 1, 2005; 77(6): 886 - 892.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
G. E. Morris, M. K. B. Whyte, G. F. Martin, P. J. Jose, S. K. Dower, and I. Sabroe
Agonists of Toll-like Receptors 2 and 4 Activate Airway Smooth Muscle via Mononuclear Leukocytes
Am. J. Respir. Crit. Care Med., April 15, 2005; 171(8): 814 - 822.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. B. Stamatiou, C.-C. Chan, G. Monneret, D. Ethier, J. Rokach, and W. S. Powell
5-Oxo-6,8,11,14-eicosatetraenoic Acid Stimulates the Release of the Eosinophil Survival Factor Granulocyte/Macrophage Colony-stimulating Factor from Monocytes
J. Biol. Chem., July 2, 2004; 279(27): 28159 - 28164.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. Nagase, S. Okugawa, Y. Ota, M. Yamaguchi, H. Tomizawa, K. Matsushima, K. Ohta, K. Yamamoto, and K. Hirai
Expression and Function of Toll-Like Receptors in Eosinophils: Activation by Toll-Like Receptor 7 Ligand
J. Immunol., October 15, 2003; 171(8): 3977 - 3982.
[Abstract] [Full Text] [PDF]

Home page
 Innate ImmunityHome page
O. Michel
Role of lipopolysaccharide (LPS) in asthma and other pulmonary conditions
Innate Immunity, October 1, 2003; 9(5): 293 - 300.
[Abstract] [PDF]

Home page
 J. Immunol.Home page
I. Sabroe, L. R. Prince, E. C. Jones, M. J. Horsburgh, S. J. Foster, S. N. Vogel, S. K. Dower, and M. K. B. Whyte
Selective Roles for Toll-Like Receptor (TLR)2 and TLR4 in the Regulation of Neutrophil Activation and Life Span
J. Immunol., May 15, 2003; 170(10): 5268 - 5275.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
I. Sabroe, E. C. Jones, L. R. Usher, M. K. B. Whyte, and S. K. Dower
Toll-Like Receptor (TLR)2 and TLR4 in Human Peripheral Blood Granulocytes: A Critical Role for Monocytes in Leukocyte Lipopolysaccharide Responses
J. Immunol., May 1, 2002; 168(9): 4701 - 4710.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2000 American Thoracic Society.